Form 4 holding
President and CSO
Silverback Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 61,639
- Estimated value
- $233,180
- Report date
- 02 May 2022
- Price
- $3.78
- Ownership
- Direct
Valerie Odegard
Insider Reports History
- Location
- Seattle, WA
- Reporting signature
- /s/ Jolie M. Siegel, Attorney-in-Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
SEC record
SEC evidence
Holdings reported by Valerie Odegard:
Form 4 holding
President and CSO
Silverback Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 90,467
- Estimated value
- Report date
- 02 May 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Odyssey Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 27,393
- Estimated value
- Report date
- 07 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Valerie Odegard
4
ODTX
Odyssey Therapeutics, Inc.
- Report period
- 07 May 2026
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 11 May 2026, 20:30
- Role
- Director
- Next action
- Open filing details
3
ODTX
Odyssey Therapeutics, Inc.
- Report period
- 07 May 2026
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 07 May 2026, 21:40
- Role
- Director
- Next action
- Open filing details
4
SPRY
Silverback Therapeutics, Inc.
- Report period
- 02 May 2022
- Transactions
- 2
- Transaction value
- $0
- Filing time
- 04 May 2022, 17:12
- Role
- President and CSO
- Next action
- Open filing details
4
SPRY
Silverback Therapeutics, Inc.
- Report period
- 01 Feb 2022
- Transactions
- 3
- Transaction value
- $0
- Filing time
- 02 Feb 2022, 16:16
- Role
- President and CSO
- Next action
- Open filing details